FDA Inspection 855708 — BioGenetics Corporation

BioGenetics Corporation — FEI 3001236618

The FDA completed an inspection of BioGenetics Corporation on Nov 14, 2013 in Mountainside, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Nov 14, 2013
Fiscal Year
2014
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Mountainside, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.